Q1 2026 · 13F-HR
Knott David M Jrholdings as filed
Filed 2026-05-14 · accession 0001104659-26-060750
$168.0M
Reported value
85
Positions
2026-03-31
Period end
The Brief · Knott David M Jr · Q1 2026
AI · grounded in 13F
Knott David M Jr closed its position in Calumet, Inc. CLMT, reducing exposure by $44.01M. The fund established new positions in Iovance Biotherapeutics, Inc. IOVA for $5.62M and LPL Financial Holdings Inc. for $4.96M. Additionally, the fund added a new stake in Relmada Therapeutics, Inc. RLMD worth $3.06M and exited positions in Tectonic Therapeutic, Inc. TECX and Biohaven LTD BHVN.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02079K107 | GOOG | Alphabet Inc-Cl C | $26.2M | 15.6% | 91,420 | Common | SOLE |
| 03769M106 | APO | Apollo Global Management, Inc. | $25.1M | 14.9% | 225,000 | Common | SOLE |
| 87164F105 | SNDX | Syndax Pharmaceutical, Inc. | $9.9M | 5.87% | 422,000 | Common | SOLE |
| 10806X102 | BBIO | Bridgebio Pharma, Inc. | $6.7M | 3.98% | 90,000 | Common | SOLE |
| 74366E102 | PTGX | Protagonist Therapeutics, Inc | $6.6M | 3.95% | 63,000 | Common | SOLE |
| 98422E103 | XERS | Xeris Biopharma Holdings, Inc. | $6.1M | 3.66% | 1,060,000 | Common | SOLE |
| 46625H100 | JPM | JPMorgan Chase & Co. | $5.7M | 3.41% | 19,477 | Common | SOLE |
| 462260100 | IOVA | Iovance Biotherapeutics, Inc. | $5.6M | 3.34% | 1,600,000 | Common | SOLE |
| 52012V100 | — | LPL Financial Holdings Inc. | $5.0M | 2.95% | 16,500 | Common | SOLE |
| 47103U845 | JAAA | Janus Henderson AAA CLO ETF | $4.7M | 2.80% | 93,528 | Common | SOLE |
| G01767105 | ALKS | Alkermes PLC | $4.2M | 2.53% | 120,000 | Common | SOLE |
| 89422G107 | TVTX | Travere Therapeutics, Inc. | $4.2M | 2.49% | 140,633 | Common | SOLE |
| 19240Q201 | COGT | Cogent Biosciences Inc. | $4.0M | 2.38% | 104,000 | Common | SOLE |
| 92790C104 | VRDN | Viridian Therapeutics, Inc. | $3.5M | 2.11% | 181,000 | Common | SOLE |
| 00847X104 | AGIO | Agios Pharmaceutical, Inc. | $3.1M | 1.87% | 93,058 | Common | SOLE |
| 75955J402 | RLMD | Relmada Therapeutics, Inc. | $3.1M | 1.82% | 439,300 | Common | SOLE |
| 88322Q108 | TGTX | TG Therapeutics, Inc. | $3.0M | 1.78% | 90,001 | Common | SOLE |
| 14888U101 | CPRX | Catalyst Pharmaceuticals, Inc. | $3.0M | 1.77% | 120,000 | Common | SOLE |
| 03940c100 | — | Arcellx Inc | $2.2M | 1.33% | 19,433 | Common | SOLE |
| 78464A870 | XBI | SPDR S&P Biotech ETF | $1.9M | 1.14% | 15,000 | Common | SOLE |
| 01881G106 | AB | AllianceBernstein Holding L.P. | $1.8M | 1.07% | 48,000 | Common | SOLE |
| 03969F109 | RCUS | Arcus Biosciences, Inc. | $1.8M | 1.04% | 81,241 | Common | SOLE |
| 256086109 | DCGO | DocGo, Inc. | $1.7M | 1.00% | 2,670,850 | Common | SOLE |
| 23256X407 | HELP | Cybin Inc | $1.7M | 1.00% | 350,000 | Common | SOLE |
| 23282W605 | CYTK | Cytokinetics, Incorporated | $1.6M | 0.93% | 23,644 | Common | SOLE |
| 152309100 | CNTA | Centessa Pharmaceuticals PLC | $1.5M | 0.92% | 39,000 | Common | SOLE |
| 04963C209 | ATRC | AtriCure, Inc. | $1.5M | 0.87% | 51,400 | Common | SOLE |
| 039697107 | ARDX | Ardelyx, Inc. | $1.2M | 0.74% | 207,000 | Common | SOLE |
| 81752T528 | CLOZ | The Panagram BBB-B CLO ETF | $1.2M | 0.73% | 47,807 | Common | SOLE |
| 478160104 | JNJ | Johnson & Johnson | $1.2M | 0.72% | 4,922 | Common | SOLE |
| 76200L309 | RZLT | Rezolute, Inc. | $1.1M | 0.67% | 370,000 | Common | SOLE |
| 68572M106 | OBIO | Orchestra Biomed Holdings, Inc. | $1.1M | 0.64% | 253,651 | Common | SOLE |
| 558868105 | MDGL | Madrigal Pharmaaceuticals, Inc. | $1.0M | 0.62% | 2,000 | Common | SOLE |
| 92337R101 | VERA | Vera Therapeutics, Inc. | $1.0M | 0.62% | 26,000 | Common | SOLE |
| G23549101 | CNTB | Connect Biopharma Holdings Limited | $1.0M | 0.60% | 387,835 | Common | SOLE |
| 464287556 | IBB | iShares Biotechnology ETF | $928,675 | 0.55% | 5,500 | Common | SOLE |
| 717081103 | PFE | Pfizer Inc. | $908,023 | 0.54% | 32,337 | Common | SOLE |
| 110122108 | BMY | Bristol-Myers Squibb Company | $826,174 | 0.49% | 13,622 | Common | SOLE |
| 136385101 | CNQ | Canadian Natural Resources Limited | $818,664 | 0.49% | 16,800 | Common | SOLE |
| 09062X103 | BIIB | Biogen Inc. | $733,320 | 0.44% | 4,000 | Common | SOLE |
| 90400D108 | RARE | Ultragenyx Pharmaceutical Inc. | $692,796 | 0.41% | 33,069 | Common | SOLE |
| 037833100 | AAPL | Apple Inc. | $632,952 | 0.38% | 2,494 | Common | SOLE |
| 594918104 | MSFT | Microsoft Corporation | $592,272 | 0.35% | 1,600 | Common | SOLE |
| 92337C203 | VSTM | Verastem Inc. | $551,200 | 0.33% | 104,000 | Common | SOLE |
| 000899104 | ADMA | ADMA Biologics, Inc. | $542,402 | 0.32% | 60,200 | Common | SOLE |
| 459200101 | IBM | International Business Machines | $519,285 | 0.31% | 2,142 | Common | SOLE |
| G111OE107 | — | Biohaven Pharmaceutical Holding Co. Ltd | $513,691 | 0.31% | 60,720 | Common | SOLE |
| 171126204 | PTHS | Pelthos Therapeutics, Inc. | $442,744 | 0.26% | 21,073 | Common | SOLE |
| 50127T109 | KURA | Kura Oncology, Inc. | $428,996 | 0.26% | 52,767 | Common | SOLE |
| 30052c107 | — | Evolus, Inc. | $408,279 | 0.24% | 99,338 | Common | SOLE |
| 230031106 | CGEM | Cullinan Therapeutics, Inc. | $343,882 | 0.20% | 24,200 | Common | SOLE |
| 83422E204 | SLDB | Solid Bioscience Inc. | $339,430 | 0.20% | 47,143 | Common | SOLE |
| 52635N103 | LENZ | LENZ Therapeutics, Inc. | $308,648 | 0.18% | 33,732 | Common | SOLE |
| Y95308105 | WVE | Wave Life Science Ltd. | $290,000 | 0.17% | 40,000 | Common | SOLE |
| 75080J103 | RAIN | Rain Enhancement Technologies Holdco Inc | $258,282 | 0.15% | 101,686 | Common | SOLE |
| 494368103 | KMB | Kimberly-Clark Corporation | $231,528 | 0.14% | 2,400 | Common | SOLE |
| 67066G104 | NVDA | Nvidia Corp | $223,290 | 0.13% | 1,280 | Common | SOLE |
| 78377T107 | RHP | Ryman Hospitality Properties, Inc. | $221,448 | 0.13% | 2,400 | Common | SOLE |
| 11135F101 | AVGO | Broadcom, Inc. | $219,859 | 0.13% | 710 | Common | SOLE |
| 609207105 | MDLZ | Mondelez International, Inc. | $172,920 | 0.10% | 3,000 | Common | SOLE |
| 26614N102 | DD | DuPont de Nemours, Inc. | $172,529 | 0.10% | 3,767 | Common | SOLE |
| 471871202 | JSPR | Jasper Therapeutics, Inc. | $140,883 | 0.08% | 160,789 | Common | SOLE |
| 00534A102 | IVVD | Invivyd, Inc. | $130,000 | 0.08% | 100,000 | Common | SOLE |
| 22052L104 | CTVA | Corteva, Inc. | $100,954 | 0.06% | 1,206 | Common | SOLE |
| 589492107 | MREO | Mereo BioPharm Group PLC | $99,111 | 0.06% | 300,337 | Common | SOLE |
| 27627N105 | EBC | Eastern Bankshares Inc | $97,800 | 0.06% | 5,000 | Common | SOLE |
| 74762E102 | QURE | Quanta Services, Inc. | $96,628 | 0.06% | 176 | Common | SOLE |
| 464287481 | IWP | iShares Russell Mid-Cap Growth | $89,043 | 0.05% | 695 | Common | SOLE |
| 02079k305 | — | Alphabet Inc CL A | $86,268 | 0.05% | 300 | Common | SOLE |
| 52472M101 | LEGH | Legacy Housing Corporation | $81,720 | 0.05% | 4,000 | Common | SOLE |
| 023135106 | AMZN | Amazon.com Inc. | $62,493 | 0.04% | 300 | Common | SOLE |
| 911363109 | URI | United Rental, Inc. | $56,828 | 0.03% | 78 | Common | SOLE |
| 260557103 | DOW | Dow Inc. | $50,230 | 0.03% | 1,206 | Common | SOLE |
| 674599105 | OXY | Occidential Pertro Wts exp. 8/3/27 | $34,730 | 0.02% | 663 | Common | SOLE |
| 235851102 | DHR | Danaher Corporation | $34,128 | 0.02% | 180 | Common | SOLE |
| G4863A108 | BRSL | Brightstar Lottery PLC | $31,850 | 0.02% | 2,500 | Common | SOLE |
| 302635107 | FSK | FS KKR Capital Corp. | $29,267 | 0.02% | 2,875 | Common | SOLE |
| 09260d107 | — | Blackstone Group LP | $24,148 | 0.01% | 210 | Common | SOLE |
| 883556102 | TMO | Thermo Fisher Scientific, Inc. | $22,119 | 0.01% | 45 | Common | SOLE |
| 91324p102 | — | United Healthcare Corp. | $15,424 | 0.01% | 57 | Common | SOLE |
| 79466L302 | CRM | Salesforce, Inc. | $14,374 | 0.01% | 77 | Common | SOLE |
| 85571B105 | STWD | Starwood Property Trust, Inc. | $6,888 | 0.00% | 400 | Common | SOLE |
| 50155Q100 | KD | Kyndryl Holdings Inc. | $5,615 | 0.00% | 428 | Common | SOLE |
| 36266G107 | GEHC | GE HealthCare Technologies Inc | $3,559 | 0.00% | 50 | Common | SOLE |
| 929740108 | WAB | Wabtec Corporation | $1,499 | 0.00% | 6 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.